Genentech to Discontinue Fuzeon® (Enfuvirtide) Amid Evolving HIV Treatment Landscape
Genentech discontinues Fuzeon (enfuvirtide) by February 2025 as advanced HIV treatments emerge. Learn how healthcare providers should transition patients to newer therapies.
Keep reading
